Finding Your Footing with an MPAN Diagnosis

Receiving a diagnosis of Mitochondrial membrane protein-associated neurodegeneration (MPAN) often brings a complex mix of emotions. For many families, this moment arrives after a “diagnostic odyssey”—a long search for answers that one registry study found lasts a median of 5 years ^[1]. You may feel a sense of relief that the symptoms finally have a name, but also feel overwhelmed by the rarity and nature of the condition. You are not alone in this; while MPAN is very rare (one exome study in a specific region estimated a frequency of 1 in 600,000 people), there is a dedicated community of researchers and clinicians working to support families like yours ^[2].

Understanding MPAN

MPAN is a rare genetic disorder caused by changes (variants) in the C19orf12 gene ^[3]. This gene provides instructions for a protein found in the mitochondria, which are the energy-producing centers of your cells. When this protein doesn’t work correctly, it affects how cells handle fats (lipids) and respond to stress, eventually leading to a buildup of iron in specific parts of the brain ^[4][5].

Because of this iron buildup, MPAN is classified as a type of Neurodegeneration with Brain Iron Accumulation (NBIA). NBIA is an umbrella term for a group of rare disorders where iron collects in the basal ganglia, a part of the brain that helps control movement ^[6].

The Course of the Disease

MPAN is a progressive condition, meaning symptoms tend to change and develop over time. While every person’s experience is unique, research has identified common patterns in cohorts:

• Onset: Symptoms most often begin in childhood, with a median age of 9 years in one large cohort, though they can sometimes appear in adulthood ^[1].
• Early Signs: The first symptoms frequently involve gait disturbances (trouble walking) and pyramidal signs, which can include muscle stiffness (spasticity) or weakness ^[1][7].
• Vision: Many people develop optic atrophy, a thinning of the nerve that sends signals from the eye to the brain, which can affect vision ^[8].
• Later Symptoms: As the condition progresses, individuals may develop dysarthria (impaired motor control of speech), dystonia (involuntary muscle contractions), or parkinsonism (tremors or slowed movement) ^[1][9].
• Cognition and Mood: Some people, especially those with adult-onset MPAN, may experience changes in thinking, memory, or behavior ^[10][6].

Progression happens at different rates for everyone. In one large study of 85 patients, researchers found that about half of the patients began using a wheelchair full-time after approximately 16 years of living with the disease ^[1]. This is an average based on a specific group of patients and is not a personal prediction.

Living with the Diagnosis

While there is currently no cure for MPAN, a multidisciplinary care approach—involving a team of different specialists—is the standard for supporting health and quality of life ^[11]. This team often includes:

• Neurologists to manage movement symptoms.
• Ophthalmologists to monitor and support vision ^[8].
• Physical and Occupational Therapists to help maintain mobility, prevent falls, and select safe assistive equipment ^[12].
• Speech-Language Pathologists to assist with communication devices and swallowing.
• Genetic Counselors to help the family understand inheritance patterns (typically recessive) and testing for relatives ^[13].

Managing MPAN focuses on addressing specific symptoms as they arise. Your care team will work with you to create a plan that prioritizes your comfort, function, and goals. Participation in research registries, such as the TIRCON International NBIA Registry, can also help scientists better understand the disease and prepare for future clinical trials [NCT05522374].